ALNY
Alnylam Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
3.54 / 10
Netural
Assessment of technical metrics shows challenging technical structure scoring 3.54/10. Constructive patterns in MACD Golden Cross contrast with challenging signals from Bearish Engulfing, MACD Death Cross, and Long Lower Shadow. Technical assessment: cautious.
Analysis Checks(1/4)
Long Lower Shadow
Score3.27/10
Win Rate50.00%
Hist. Signals8
Avg Return-0.93%
Score3.27/10
Win Rate50.00%
Hist. Signals8
Avg Return-0.93%
MACD Death Cross
Score1/10
Win Rate30.00%
Hist. Signals10
Avg Return-1.32%
Score1/10
Win Rate30.00%
Hist. Signals10
Avg Return-1.32%
Bearish Engulfing
Score2.75/10
Win Rate44.44%
Hist. Signals9
Avg Return-0.24%
Score2.75/10
Win Rate44.44%
Hist. Signals9
Avg Return-0.24%
MACD Golden Cross
Score7.14/10
Win Rate62.50%
Hist. Signals8
Avg Return3.73%
Score7.14/10
Win Rate62.50%
Hist. Signals8
Avg Return3.73%
Long Lower Shadow
Score3.27/10
Win Rate50.00%
Hist. Signals8
Avg Return-0.93%
Score3.27/10
Win Rate50.00%
Hist. Signals8
Avg Return-0.93%
Bearish Engulfing
Score2.75/10
Win Rate44.44%
Hist. Signals9
Avg Return-0.24%
Score2.75/10
Win Rate44.44%
Hist. Signals9
Avg Return-0.24%
MACD Death Cross
Score1/10
Win Rate30.00%
Hist. Signals10
Avg Return-1.32%
Score1/10
Win Rate30.00%
Hist. Signals10
Avg Return-1.32%
MACD Golden Cross
Score7.14/10
Win Rate62.50%
Hist. Signals8
Avg Return3.73%
Score7.14/10
Win Rate62.50%
Hist. Signals8
Avg Return3.73%
What is the current technical signals for ALNY?
- ALNY presents a Netural setup with a Technical Score of 3.54/10. Key technical indicators highlight an RSI of 29.78 and a MACD of -1.42, with the trend anchored by the 50-Day SMA at 392.55. Traders should monitor key support at 322.17 and resistance at 345.40.
